Importer of Controlled Substances; Notice of Application; Research Triangle Institute, 46369-46371 [2013-18330]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 147 / Wednesday, July 31, 2013 / Notices
Nos. 5,434,480 (‘‘the ’480 patent’’) and
8,035,318 (‘‘the ’318 patent’’). The
complaint named numerous
respondents, many of whom have been
terminated from the investigation on the
basis of settlement agreement, consent
order, or withdrawal of the complaint.
By the time of the Administrative Law
Judge’s final Initial Determination
(‘‘ID’’), the remaining respondents were:
Technical Consumer Products, Inc. of
Aurora, Ohio; Shanghai Qiangling
Electronics Co., Ltd. of Shanghai, China;
Zhejiang Qiang Ling Electronic Co. Ltd.
of Zhenjiang, China (collectively,
‘‘TCP’’); U Lighting America Inc. of San
Jose, California (‘‘ULA’’); and Golden U
Lighting Manufacturing (Shenzhen) of
Shenzhen, China (‘‘Golden U’’). Claim 9
of the ’480 patent has been asserted
against ULA and Golden U, and claims
1 and 12 of the ’318 patent have been
asserted against TCP.
On February 27, 2013, the ALJ issued
his final Initial Determination (‘‘ID’’).
The ID found Golden U in default, but
found no violation of section 337 as to
all remaining respondents on the basis
of Neptun’s failure to satisfy the
economic prong of the domestic
industry requirement of section 337.
The ALJ also found that respondent
TCP’s accused products do not infringe
the asserted claims of the ’318 patent.
On March 12, 2013, Neptun filed a
petition for review of the ID; TCP and
ULA each filed a contingent petition for
review of the ID. On March 20, 2013,
Neptun opposed TCP’s and ULA’s
petitions, and TCP and ULA each
opposed Neptun’s petition. On April 3,
2013, the Commission extended the
whether-to-review deadline and the
target date by approximately six weeks.
Notice (Apr. 3, 2013).
On June 10, 2013, Neptun and TCP
filed an unopposed joint motion to
terminate the investigation as to TCP on
the basis of a settlement agreement
between Neptun and TCP. On June 12,
2013, the Commission issued a notice
terminating the investigation as to TCP.
That notice also determined to review,
inter alia, the ALJ’s finding that Neptun
did not demonstrate the existence of a
domestic industry. On June 25, 2013,
Neptun and ULA filed briefs in response
to the Commission notice. Neptun and
ULA subsequently requested extensions
of time for the filing of replies in order
to enable them to submit a motion
terminating the investigation against
ULA.
On July 10, 2013, Neptun and ULA
moved to terminate the investigation
against ULA on the basis of a settlement
agreement. On July 15, 2013, Neptun
moved to terminate the investigation
against Golden U on the basis of
VerDate Mar<15>2010
16:14 Jul 30, 2013
Jkt 229001
withdrawal of the complaint.
Termination against these two
respondents results in termination of
the investigation. The Commission has
determined that termination as to the
remaining respondents is in the public
interest, and the Commission has
determined to grant both motions. The
Commission thereby terminates the
investigation.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in
sections 210.21 and 210.42–46 of the
Commission’s Rules of Practice and
Procedure (19 CFR 210.21, 210.42–46).
By order of the Commission.
Issued: July 26, 2013.
Lisa R. Barton,
Acting Secretary to the Commission.
46369
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Acting Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States and State of Texas
v. San Antonio Water System, D.J. Ref.
No. 90–5–1–1–09215. All comments
must be submitted no later than thirty
(30) days after the publication date of
this notice. Comments may be
submitted either by email or by mail:
To submit
comments:
Send them to:
By e-mail ......
pubcommentees.enrd@usdoj.gov.
Acting Assistant Attorney
General, U.S. DOJ—ENRD,
P.O. Box 7611, Washington, D.C. 20044–7611.
By mail .........
[FR Doc. 2013–18392 Filed 7–30–13; 8:45 am]
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department Web site: https://
DEPARTMENT OF JUSTICE
www.usdoj.gov/enrd/
Consent_Decrees.html. We will provide
Notice of Lodging of Proposed
a paper copy of the Consent Decree
Consent Decree Under the Clean Water upon written request and payment of
Act
reproduction costs. Please mail your
request and payment to: Consent Decree
On July 23, 2013, the Department of
Library, U.S. DOJ—ENRD, P.O. Box
Justice lodged a proposed Consent
7611, Washington, DC 20044–7611.
Decree with the United States District
Please enclose a check or money order
Court for the Western District of Texas
for $21.50 (25 cents per page
in the lawsuit entitled United States and
reproduction cost) payable to the United
State of Texas v. San Antonio Water
States Treasury for a copy of the
System, Civil Action No. 5:13–cv–
Consent Decree without the
00666.
Appendices, or a check or money order
This civil action for injunctive relief
for $39.00 for a copy of the Consent
and civil penalties was initiated
Decree with Appendices A–H.
pursuant to Sections 301 and 309 of the
Robert E. Maher, Jr.,
Clean Water Act (‘‘CWA’’), 33 U.S.C.
§§ 1311 and 1319, and provisions of the Assistant Section Chief, Environmental
Enforcement Section, Environment and
Texas Water Code (‘‘TWC’’) against the
Natural Resources Division.
San Antonio Water System (‘‘SAWS’’),
[FR Doc. 2013–18404 Filed 7–30–13; 8:45 am]
San Antonio, Bexar County, Texas, for:
(a) Discharges of pollutants, including
BILLING CODE 4410–15–P
discharges from unpermitted point
sources, in violation of Section 301 of
DEPARTMENT OF JUSTICE
the CWA, 33 U.S.C. § 1311, and
provisions of the TWC; and (b)
Drug Enforcement Administration
violations of effluent limitations and
other conditions established in National Importer of Controlled Substances;
Pollutant Discharge Elimination System Notice of Application; Research
(also known as Texas Pollutant
Triangle Institute
Discharge Elimination System or
Pursuant to Title 21 Code of Federal
TPDES) permits issued to SAWS. Under
Regulations 1301.34 (a), this is notice
the proposed Consent Decree, SAWS
has agreed to implement comprehensive that on March 20, 2013, Research
Triangle Institute, Poonam G. Pande,
injunctive relief measures designed to
address and eliminate illegal discharges Ph.D. RPH, RAC, Hermann Building,
East Institute Drive, P.O. Box 12194,
or sanitary sewer overflows and
Research Triangle Park, North Carolina
violations of effluent limits. SAWS will
27709, made application by renewal to
pay a $2.6 million civil penalty, which
the Drug Enforcement Administration
will be split between the United States
(DEA) for registration as an importer of
and the State.
BILLING CODE 7020–02–P
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\31JYN1.SGM
31JYN1
46370
Federal Register / Vol. 78, No. 147 / Wednesday, July 31, 2013 / Notices
the following basic classes of controlled
substances:
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
AM–2201 (7201) ...........................
AM–694 (7694) .............................
JWH–018 (7118) ..........................
JWH–073 (7173) ..........................
JWH–200 (7200) ..........................
JWH–250 (6250) ..........................
JWH–019 (7019) ..........................
JWH–081 (7081) ..........................
SR–19 and RCS–4 (7104) ...........
JWH–122 (7122) ..........................
JWH–203 (7203) ..........................
JWH–398 (7398) ..........................
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
1-[1-(2Thienyl)cyclohexyl]pyrrolidine
(7473).
1-Methyl-4-phenyl-4propionoxypiperidine (9661).
1-(2-Phenylethyl)-4-phenyl-4acetoxypiperidine (9663).
2,5-Dimethoxy-4-(n)propylthiophenethylamine
(7348).
2,5-Dimethoxy-4ethylamphetamine (7399).
2,5-Dimethoxyamphetamine
(7396).
2C–D (7508) .................................
2C–E (7509) .................................
2C–H (7517) .................................
2C–N (7521) .................................
2C–P (7524) .................................
2C–T–2 (7385) .............................
2C–T–7 (7348) .............................
2C–I (7518) ..................................
2C–C (7519) .................................
2C–T–4 (7532) .............................
3,4,5-Trimethoxyamphetamine
(7390).
3,4-Methylenedioxyamphetamine
(7400).
3,4Methylenedioxymethamphetamine (7405).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3-Methylfentanyl (9813) ................
3-Methylthiofentanyl (9833) ..........
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
4-Methylaminorex (cis isomer)
(1590).
4-Methoxyamphetamine (7411) ...
CP–47497 C8 Homologue (7298)
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
5-Methoxy-N,Ndimethyltryptamine (7431).
5-Methoxy-N,Ndiisopropyltryptamine (7439).
Acetorphine (9319) .......................
VerDate Mar<15>2010
16:14 Jul 30, 2013
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 229001
Drug
Schedule
Acetyl-alpha-methylfentanyl
(9815).
Acetyldihydrocodeine (9051) ........
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alpha-ethyltryptamine (7249) .......
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Alpha-methylfentanyl (9814) ........
Alpha-methylthiofentanyl (9832) ...
Alpha-methyltryptamine (7432) ....
Aminorex (1585) ...........................
Benzethidine (9606) .....................
Benzylmorphine (9052) ................
Betacetylmethadol (9607) ............
Beta-hydroxy-3-methylfentanyl
(9831).
Beta-hydroxyfentanyl (9830) ........
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Bufotenine (7433) .........................
CP–47497 (7297) .........................
Cathinone (1235) ..........................
Clonitazene (9612) .......................
Codeine methylbromide (9070) ....
Codeine-N-Oxide (9053) ..............
Cyprenorphine (9054) ..................
Desomorphine (9055) ...................
Dextromoramide (9613) ...............
Diampromide (9615) .....................
Diethylthiambutene (9616) ...........
Diethyltryptamine (7434) ..............
Difenoxin (9168) ...........................
Dihydromorphine (9145) ...............
Dimenoxadol (9617) .....................
Dimepheptanol (9618) ..................
Dimethylthiambutene (9619) ........
Dimethyltryptamine (7435) ...........
Dioxaphetyl butyrate (9621) .........
Dipipanone (9622) ........................
Drotebanol (9335) ........................
Ethylmethylthiambutene (9623) ....
Etonitazene (9624) .......................
Etorphine except HCl (9056) ........
Etoxeridine (9625) ........................
Fenethylline (1503) .......................
Furethidine (9626) ........................
Gamma
Hydroxybutyric
Acid
(2010).
Heroin (9200) ...............................
Hydromorphinol (9301) .................
Hydroxypethidine (9627) ..............
Ibogaine (7260) ............................
Ketobemidone (9628) ...................
Levomoramide (9629) ..................
Levophenacylmorphan (9631) ......
Lysergic acid diethylamide (7315)
MDPV (7535) ................................
Marihuana (7360) .........................
Mecloqualone (2572) ....................
Mephedrone (1248) ......................
Mescaline (7381) ..........................
Methaqualone (2565) ...................
Methcathinone (1237) ..................
Methyldesorphine (9302) ..............
Methyldihydromorphine (9304) .....
Methylone (7540) .........................
Morpheridine (9632) .....................
Morphine methylbromide (9305) ..
Morphine methylsulfonate (9306)
Morphine-N-Oxide (9307) .............
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Drug
Myrophine (9308) .........................
N,N-Dimethylamphetamine (1480)
N-Benzylpiperazine (7493) ...........
N-Ethyl-3-piperidyl
benzilate
(7482).
N-Ethylamphetamine (1475) ........
N-Ethyl-1-phenylcyclohexylamine
(7455).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
Nicocodeine (9309) ......................
Nicomorphine (9312) ....................
N-Methyl-3-piperidyl
benzilate
(7484).
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Normorphine (9313) .....................
Norpipanone (9636) .....................
Para-Fluorofentanyl (9812) ..........
Parahexyl (7374) ..........................
Peyote (7415) ...............................
Phenadoxone (9637) ....................
Phenampromide (9638) ................
Phenomorphan (9647) .................
Phenoperidine (9641) ...................
Pholcodine (9314) ........................
Piritramide (9642) .........................
Proheptazine (9643) .....................
Properidine (9644) ........................
Propiram (9649) ...........................
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Racemoramide (9645) ..................
SR–18 and RCS–8 (7008) ...........
Tetrahydrocannabinols (7370) .....
Thebacon (9315) ..........................
Thiofentanyl (9835) ......................
Tilidine (9750) ...............................
Trimeperidine (9646) ....................
1-Phenylcyclohexylamine (7460)
1Piperidinocyclohexanecarbonitrile (8603).
4-Anilino-N-phenethyl-4-piperidine
(8333).
Alfentanil (9737) ...........................
Alphaprodine (9010) .....................
Amobarbital (2125) .......................
Amphetamine (1100) ....................
Anileridine (9020) .........................
Bezitramide (9800) .......................
Carfentanil (9743) .........................
Coca Leaves (9040) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Dihydrocodeine (9120) .................
Dihydroetorphine (9334) ...............
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Etorphine HCl (9059) ...................
Fentanyl (9801) ............................
Glutethimide (2550) ......................
Hydrocodone (9193) .....................
Hydromorphone (9150) ................
Isomethadone (9226) ...................
Levo-alphacetylmethadol (9648) ..
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Lisdexamfetamine (1205) .............
E:\FR\FM\31JYN1.SGM
31JYN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Federal Register / Vol. 78, No. 147 / Wednesday, July 31, 2013 / Notices
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with NOTICES
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Meperidine intermediate-C (9234)
Metazocine (9240) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Metopon (9260) ............................
Moramide intermediate (9802) .....
Morphine (9300) ...........................
Nabilone (7379) ............................
Opium, raw (9600) .......................
Opium extracts (9610) ..................
Opium fluid extract (9620) ............
Opium tincture (9630) ..................
Opium poppy/Poppy Straw (9650)
Oripavine (9330) ...........................
Poppy Straw Concentrate (9670)
Opium, granulated (9640) ............
Oxycodone (9143) ........................
Oxymorphone (9652) ...................
Pentobarbital (2270) .....................
Phenazocine (9715) .....................
Phencyclidine (7471) ....................
Phenmetrazine (1631) ..................
Phenylacetone (8501) ..................
Piminodine (9730) ........................
Powdered opium (9639) ...............
Racemethorphan (9732) ..............
Racemorphan (9733) ...................
Remifentanil (9739) ......................
Secobarbital (2315) ......................
Sufentanil (9740) ..........................
Tapentadol (9780) ........................
Thebaine (9333) ...........................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–18330 Filed 7–30–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Meda
Pharmaceuticals, Inc.
The company plans to import small
quantities of the listed controlled
substances for the National Institute on
Drug Abuse (NIDA) for research
activities.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances listed in schedule I or II,
which fall under the authority of section
1002(a)(2)(B) of the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances
set forth in 21 U.S.C. 958(i), file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR § 1301.43 and in such form
as prescribed by 21 CFR § 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 30, 2013.
VerDate Mar<15>2010
16:14 Jul 30, 2013
Jkt 229001
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
§ 1301.34(b), (c), (d), (e), and (f). As
noted in a previous notice published in
the Federal Register on September 23,
1975, 40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
By Notice dated February 8, 2013, and
published in the Federal Register on
February 21, 2013, 78 FR 12101, Meda
Pharmaceuticals, Inc., 705 Eldorado
Street, Decatur, Illinois 62523, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of Nabilone
(7379), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance as a finished
drug product in dosage form for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Meda Pharmaceuticals Inc., to import
the basic class of controlled substance is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Meda Pharmaceuticals
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
46371
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–18332 Filed 7–30–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Almac Clinical
Services, Inc.
By Notice dated April 10, 2013, and
published in the Federal Register on
April 19, 2013, 78 FR 23594, Almac
Clinical Services, Inc., (ACSI), 25 Fretz
Road, Souderton, Pennsylvania 18964,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
Drug
Oxycodone (9143) .........................
Hydromorphone (9150) .................
Tapentadol (9780) .........................
Fentanyl (9801) .............................
Schedule
II
II
II
II
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
The import of the above listed basic
classes of controlled substances will be
granted only for analytical testing and
clinical trials. This authorization does
not extend to the import of a finished
FDA approved or non-approved dosage
forms for commercial distribution in the
United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Almac Clinical Services, Inc., (ACSI) to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Almac Clinical Services, Inc., (ACSI) to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 78, Number 147 (Wednesday, July 31, 2013)]
[Notices]
[Pages 46369-46371]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-18330]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application;
Research Triangle Institute
Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this
is notice that on March 20, 2013, Research Triangle Institute, Poonam
G. Pande, Ph.D. RPH, RAC, Hermann Building, East Institute Drive, P.O.
Box 12194, Research Triangle Park, North Carolina 27709, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as an importer of
[[Page 46370]]
the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
AM-2201 (7201)............................. I
AM-694 (7694).............................. I
JWH-018 (7118)............................. I
JWH-073 (7173)............................. I
JWH-200 (7200)............................. I
JWH-250 (6250)............................. I
JWH-019 (7019)............................. I
JWH-081 (7081)............................. I
SR-19 and RCS-4 (7104)..................... I
JWH-122 (7122)............................. I
JWH-203 (7203)............................. I
JWH-398 (7398)............................. I
1-(1-Phenylcyclohexyl)pyrrolidine (7458)... I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine I
(7473).
1-Methyl-4-phenyl-4-propionoxypiperidine I
(9661).
1-(2-Phenylethyl)-4-phenyl-4- I
acetoxypiperidine (9663).
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
2,5-Dimethoxyamphetamine (7396)............ I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-2 (7385).............................. I
2C-T-7 (7348).............................. I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-T-4 (7532).............................. I
3,4,5-Trimethoxyamphetamine (7390)......... I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxymethamphetamine (7405)... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3-Methylfentanyl (9813).................... I
3-Methylthiofentanyl (9833)................ I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
4-Methylaminorex (cis isomer) (1590)....... I
4-Methoxyamphetamine (7411)................ I
CP-47497 C8 Homologue (7298)............... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
5-Methoxy-N,N-dimethyltryptamine (7431).... I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
Acetorphine (9319)......................... I
Acetyl-alpha-methylfentanyl (9815)......... I
Acetyldihydrocodeine (9051)................ I
Acetylmethadol (9601)...................... I
Allylprodine (9602)........................ I
Alphacetylmethadol except levo- I
alphacetylmethadol (9603).
Alpha-ethyltryptamine (7249)............... I
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Alpha-methylfentanyl (9814)................ I
Alpha-methylthiofentanyl (9832)............ I
Alpha-methyltryptamine (7432).............. I
Aminorex (1585)............................ I
Benzethidine (9606)........................ I
Benzylmorphine (9052)...................... I
Betacetylmethadol (9607)................... I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Beta-hydroxyfentanyl (9830)................ I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Bufotenine (7433).......................... I
CP-47497 (7297)............................ I
Cathinone (1235)........................... I
Clonitazene (9612)......................... I
Codeine methylbromide (9070)............... I
Codeine-N-Oxide (9053)..................... I
Cyprenorphine (9054)....................... I
Desomorphine (9055)........................ I
Dextromoramide (9613)...................... I
Diampromide (9615)......................... I
Diethylthiambutene (9616).................. I
Diethyltryptamine (7434)................... I
Difenoxin (9168)........................... I
Dihydromorphine (9145)..................... I
Dimenoxadol (9617)......................... I
Dimepheptanol (9618)....................... I
Dimethylthiambutene (9619)................. I
Dimethyltryptamine (7435).................. I
Dioxaphetyl butyrate (9621)................ I
Dipipanone (9622).......................... I
Drotebanol (9335).......................... I
Ethylmethylthiambutene (9623).............. I
Etonitazene (9624)......................... I
Etorphine except HCl (9056)................ I
Etoxeridine (9625)......................... I
Fenethylline (1503)........................ I
Furethidine (9626)......................... I
Gamma Hydroxybutyric Acid (2010)........... I
Heroin (9200).............................. I
Hydromorphinol (9301)...................... I
Hydroxypethidine (9627).................... I
Ibogaine (7260)............................ I
Ketobemidone (9628)........................ I
Levomoramide (9629)........................ I
Levophenacylmorphan (9631)................. I
Lysergic acid diethylamide (7315).......... I
MDPV (7535)................................ I
Marihuana (7360)........................... I
Mecloqualone (2572)........................ I
Mephedrone (1248).......................... I
Mescaline (7381)........................... I
Methaqualone (2565)........................ I
Methcathinone (1237)....................... I
Methyldesorphine (9302).................... I
Methyldihydromorphine (9304)............... I
Methylone (7540)........................... I
Morpheridine (9632)........................ I
Morphine methylbromide (9305).............. I
Morphine methylsulfonate (9306)............ I
Morphine-N-Oxide (9307).................... I
Myrophine (9308)........................... I
N,N-Dimethylamphetamine (1480)............. I
N-Benzylpiperazine (7493).................. I
N-Ethyl-3-piperidyl benzilate (7482)....... I
N-Ethylamphetamine (1475).................. I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
Nicocodeine (9309)......................... I
Nicomorphine (9312)........................ I
N-Methyl-3-piperidyl benzilate (7484)...... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Normorphine (9313)......................... I
Norpipanone (9636)......................... I
Para-Fluorofentanyl (9812)................. I
Parahexyl (7374)........................... I
Peyote (7415).............................. I
Phenadoxone (9637)......................... I
Phenampromide (9638)....................... I
Phenomorphan (9647)........................ I
Phenoperidine (9641)....................... I
Pholcodine (9314).......................... I
Piritramide (9642)......................... I
Proheptazine (9643)........................ I
Properidine (9644)......................... I
Propiram (9649)............................ I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Racemoramide (9645)........................ I
SR-18 and RCS-8 (7008)..................... I
Tetrahydrocannabinols (7370)............... I
Thebacon (9315)............................ I
Thiofentanyl (9835)........................ I
Tilidine (9750)............................ I
Trimeperidine (9646)....................... I
1-Phenylcyclohexylamine (7460)............. II
1-Piperidinocyclohexanecarbonitrile (8603). II
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Alfentanil (9737).......................... II
Alphaprodine (9010)........................ II
Amobarbital (2125)......................... II
Amphetamine (1100)......................... II
Anileridine (9020)......................... II
Bezitramide (9800)......................... II
Carfentanil (9743)......................... II
Coca Leaves (9040)......................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Dihydrocodeine (9120)...................... II
Dihydroetorphine (9334).................... II
Diphenoxylate (9170)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Etorphine HCl (9059)....................... II
Fentanyl (9801)............................ II
Glutethimide (2550)........................ II
Hydrocodone (9193)......................... II
Hydromorphone (9150)....................... II
Isomethadone (9226)........................ II
Levo-alphacetylmethadol (9648)............. II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Lisdexamfetamine (1205).................... II
[[Page 46371]]
Meperidine (9230).......................... II
Meperidine intermediate-A (9232)........... II
Meperidine intermediate-B (9233)........... II
Meperidine intermediate-C (9234)........... II
Metazocine (9240).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Metopon (9260)............................. II
Moramide intermediate (9802)............... II
Morphine (9300)............................ II
Nabilone (7379)............................ II
Opium, raw (9600).......................... II
Opium extracts (9610)...................... II
Opium fluid extract (9620)................. II
Opium tincture (9630)...................... II
Opium poppy/Poppy Straw (9650)............. II
Oripavine (9330)........................... II
Poppy Straw Concentrate (9670)............. II
Opium, granulated (9640)................... II
Oxycodone (9143)........................... II
Oxymorphone (9652)......................... II
Pentobarbital (2270)....................... II
Phenazocine (9715)......................... II
Phencyclidine (7471)....................... II
Phenmetrazine (1631)....................... II
Phenylacetone (8501)....................... II
Piminodine (9730).......................... II
Powdered opium (9639)...................... II
Racemethorphan (9732)...................... II
Racemorphan (9733)......................... II
Remifentanil (9739)........................ II
Secobarbital (2315)........................ II
Sufentanil (9740).......................... II
Tapentadol (9780).......................... II
Thebaine (9333)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the National Institute on Drug Abuse (NIDA)
for research activities.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR Sec. 1301.43 and in such form as prescribed by 21
CFR Sec. 1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than August 30, 2013.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR Sec. 1301.34(b),
(c), (d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants
for registration to import a basic class of any controlled substances
in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: July 23, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-18330 Filed 7-30-13; 8:45 am]
BILLING CODE 4410-09-P
